No Data
No Data
List of stocks breaking through clouds (weekly) (part 2)
○ List of Stocks Breaking Through the Clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <6103> Okuma 3515 3355.5 3355.5 <6104> Shibaura Machine 3725 3480 3695 <6140> Asahi Diamond 8958 67.7 868.5 <6201> Toyota Industries 1267 0120 124 1286.5 <6331> Mitsubishi Kakoki 3765 3659.2 53521.5
List of convertible stocks (Part 5) [List of stocks with Parabolic Cigna Corp signals]
○ List of stocks converted to Sell in the market Code Stock Name Closing Price SAR Main Board <7718> Canon Inc-Spons Adr 1925 <7721> Tokyo Keiki 30053365 <7723> Aichi Clock 18621948 <7733> Olympus 22652396 <7744> Noritz Steel Co., Ltd. 48205120 <7747> Asahi Intec 25552699 <7751> Canon Inc-Spons Adr 49235097 <7
Marusan Securities: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)
January 21 [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 Estrast <3280> 737 yen (1/20) Engaged in the planning and sales of the condominium "Ovision Mansion" in Yamaguchi and Fukuoka. Announced that the Financial Estimates for the year-end Dividends for the fiscal year ending February 2025 are expected to be 14 yen. The previous estimate was 12 yen, and the year-end Dividends for the previous fiscal year were 11 yen. Annual Dividends will be 26 yen. The previous estimate was 24 yen, and the annual Dividends for the previous fiscal year were 22 yen. Aiming to achieve stable profit returns to Shareholders with management mindful of capital costs and stock prices.
Focus on Sanjyu Construction and Sumitomo Pharma.
Yesterday, on the 20th, the U.S. stock market was closed for the Martin Luther King Jr. Day holiday, and the exchange rate was 1 dollar = 155.60-70 yen. In today's Tokyo market, Marusan Securities <8613> announced its summary of cumulative third-quarter earnings, expecting operating profit to increase by 36.2%. Mitsui Construction <1821> announced that it would raise the lower limit of its self-capital dividend rate (DOE) for the next medium-term management plan period (FY25-FY27) to 4%, up from 3% for FY22-FY24. Johnson & Johnson and the long-acting atypical antipsychotic 'Zep.'
Zain, upward revision on 24/12, operating profit 28 million yen, from 10 million yen.
Zain Co., Ltd. (6769) has announced a revision of its financial estimates for the fiscal year ending December 2024. Operating profit has been revised upwards from 10 million yen to 28 million yen. Both the LSI and AIOT businesses are generally progressing as expected regarding revenue for the fourth quarter; however, in terms of selling, general and administrative expenses, while research and development activities are progressing smoothly, cost reductions have been achieved, resulting in an overall expectation of a slight reduction from the initial plan, and operating profit is expected to increase compared to the initial plan. 【Positive Evaluation】 (2437)